Poor inter-test reliability between CK18 kits as a biomarker of NASH

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) affects 15–40% of the general population, 10–20% of those patients have a more severe form of the disease known as non-alcoholic steatohepatitis (NASH). Cytokeratin-18 (CK18), released during apoptosis and one of the most studied biomark...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dig Dis Sci
Main Authors: Pimentel, Carolina F. M. G., Jiang, Zhenghui G, Otsubo, Takeshi, Feldbrügge, Linda, Challies, Tracy L, Nasser, Imad, Robson, Simon, Afdhal, Nezam, Lai, Michelle
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4761280/
https://ncbi.nlm.nih.gov/pubmed/26462489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3916-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados